For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Sofia 1784

0 studies enrolling now · 15 studies all time

What they study most

Acute Coronary Syndrome, Alzheimer's Disease, Asthma, Autoimmune Disease, Cardiovascular Disease, Cardiovascular Diseases, Connective Tissue Disease, Diabetes Mellitus, Diabetes Mellitus, Type 2, Diabetic Nephropathy, Non-Small Cell Lung Cancer, Psoriasis

Studies at this site

• A Study in Participants With Moderate to Severe Psoriasis (UNCOVER-3) — Completed
• A Long-Term Efficacy and Safety Study of Ixekizumab (LY2439821) in Participants With Active Psoriatic Arthritis — Completed
• A Study of Evacetrapib in High-Risk Vascular Disease — Stopped early
• Researching Cardiovascular Events With a Weekly Incretin in Diabetes (REWIND) — Completed
• Study of LY3016859 in Participants With Diabetic Nephropathy — Completed
• Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD — Completed
• A Study of Ixekizumab in Participants With Active Psoriatic Arthritis — Completed
• A Study of Participants With Relapsing-Remitting Multiple Sclerosis (RRMS) — Completed
• A Study of LY2127399 in Participants With Systemic Lupus Erythematosus — Completed
• An Open Label Study for Participants With Rheumatoid Arthritis — Stopped early
• A Rheumatoid Arthritis Study in Participants on a Background Treatment of Methotrexate — Stopped early
• A Rheumatoid Arthritis Study in Participants — Completed
• Effects of LY450139, on the Progression of Alzheimer's Disease as Compared With Placebo — Completed
• Pemetrexed and Best Supportive Care Versus Placebo and Best Supportive Care in Non-Small Cell Lung Cancer (NSCLC) — Completed
• A Comparison of Prasugrel and Clopidogrel in Acute Coronary Syndrome Subjects — Completed